Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians

Metabolism: Clinical and Experimental

Volumn 47, Issue 5, 1998, Pages 622-626

  Nagi, D K ^a   Foy, C A ^b   Mohamed Ali, V ^b   Yudkin, J S ^b   Grant, P J ^b   Knowler, W C ^b  

^a PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; AGED; AMERICAN INDIAN; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ELECTROCARDIOGRAM; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031948787     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90250-5     Document Type: Article

References (38)

1. Ballerman BJ, Zeidel ML, Gunning ME, et al: Vasoactive peptides and the kidney, in Brenner BM, Rector FC (eds): The Kidney (ed 4). Philadelphia, PA, Saunders, 1991, pp 510-583
2. Rigat B, Hubert C, Alhenc-Gelas F, et al: An insertion deletion polymorphism in angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
3. Jan Danser AH, Maarten ADH, Bax WA, et al: Angiotensin-converting enzyme in the human heart: Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388, 1995
4. Tiret L, Kee F, Poirier O, et al: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 341:991-992, 1993
5. Lindpaintner C, Pfeffer MA, Kreutz R, et al: A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischaemic heart disease. N Engl J Med 332:706-711, 1995
6. Ruiz J, Blanche H, Cohen N, et al: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary artery disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91:3662-3665, 1994
7. Keavney B, Dudley CR, Stratton IM, et al: UK Prospective Diabetes Study. XIV. Association of angiotensin converting enzyme insertion/deletion gene polymorphism with myocardial infarction in type 2 diabetes. Diabetologia 38:948-952, 1995
8. Wierzbiciki AS, Nimmo L, Feher MD, et al: Association of angiotensin converting enzyme DD genotype with hypertension in diabetes. J Hum Hypertens 9:671-673, 1995
9. Pujia A, Gnasso A, Irace C, et al: Association between ACE-D/D polymorphism and hypertension in type II diabetic subjects. J Hum Hypertens 8:687-691, 1994
10. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
11. Stern MP: Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 44:369-374, 1995
12. Knowler WC, Pettit DJ, Saad MF, et al: Diabetes mellitus in Pima Indians: Incidence, risk factors and pathogenesis. Diabetes Metab Rev 6:1-27, 1990
13. Ingelfinger JA, Bennett PH, Liebow IM, et al: Coronary heart disease in the Pima Indians: Electrocardiographic findings and postmortem evidence of myocardial infarction in a population with a high prevalence of diabetes mellitus. Diabetes 25:561-565, 1976
14. Nelson RG, Sievers ML, Knowler WC, et al: Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 81:987-995, 1990
15. Foy CA, McCormack LJ, Knowler WC, et al: The angiotensin-1 converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians. J Med Genet 33:336-337, 1996
16. Epstein FH, Ostrander LD, Johnson BC, et al: Epidemiological studies of cardiovascular disease in a total community - Tecumseh, Michigan. Ann Intern Med 62:1170-1187, 1965
17. Chmielewska J, Ranby M, Wiman B: Evidence of a rapid inhibitor to tissue plasminogen activators in plasma. Thromb Res 31:427-436, 1983
18. Mohamed-Ali V, Gould MM, Gillies S, et al: Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects - Evidence against a modulating role for insulin. Diabetologia 38:1110-1116, 1995
19. Mohamed-Ali V, Nagi DK, Yudkin JS: Sensitive microplate IRMAs for intact and des 31,32 proinsulin compared with HPLC and cellulose IRMAs. Clin Chem 42:977-979, 1996
20. World Health Organization: Diabetes mellitus. Report of a WHO Study Group. World Health Organization Technical Report Series 727, 1985
21. Rigat B, Hubert C, Corvol P, et al: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl-carboxy peptidase 1). Nucleic Acids Res 20:1433, 1992 (abstr)
22. Shanmugam V, Sell K, Saha B: Mistyping ACE heterozygotes. PCR Methods Applic 3:120-121, 1993
23. Leiberman J, Sastre A: Serum angiotensin converting enzyme: Elevations in diabetes mellitus. Ann Intern Med 93:825-826, 1980
24. Katsuya T, Horiuchi M, Chen YD, et al: Relations between deletion polymorphism of the angiotensin converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinaemia, and dyslipidaemia. Arterioscler Thromb Vasc Biol 15:779-782, 1995
25. Panahaloo A, Andres A, Mohamed-Ali V, et al: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 92:3390-3393, 1995
26. Wiemer G, Scholkens BA, Linz W: Endothelial protection by converting enzyme inhibitors. Cardiovasc Res 28:166-172, 1994
27. Holtz J, Goetz RM: Vascular renin-angiotensin system, endothelial function and atherosclerosis? Basic Res Cardiol 89:71-86, 1994
28. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 327:685-691, 1992
29. Khan I, MacCleod AM: ACE genotype and progression of diabetic nephropathy. Lancet 345:570, 1995
30. Van Essen G, Rensma PL, de Zeeuw D, et al: Association between angiotensin converting enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347:94-95, 1996
31. Cooper R, McFarlane-Anderson N, Bennett FI, et al: ACE, angiotensin and obesity: A potential pathway leading to hypertension. J Hum Hypertens 11:107-111, 1997
32. Shenoy U, Cassis L: Characterisation of renin activity in brown adipose tissue. Am J Physiol 272:C989-C999, 1997
33. Crandall DL, Herzlinger HE, Saunders BD, et al: Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res 35:1378-1385, 1994
34. Hennes MM, O'Shaughnessy IM, Kelly TM, et al: Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system. Hypertension 28:120-126, 1996
35. Phillips M, Speakman E, Kimura B: Levels of angiotensin and molecular biology of the tissue renin angiotensin system. Regul Pep 434:1-120, 1993
36. The Enalapril in Hypertension Study Group (UK): Enalapril in essential hypertension: A comparative study with propranolol. Br J Clin Pharmacol 18:51-56, 1994
37. Mcgrath B, Matthews PG, Louis W, et al: Double blind study of dilevarol and captopril, both in combination with hydrochlorothiazide, in patients with moderate to severe hypertension. J Cardiovasc Pharmacol 16:831-838, 1990
38. Alhenc-Gelas F, Richard J, Courbon D, et al: Distribution of plasma angiotensin converting enzyme in healthy men: Relationship to environmental and hormonal parameters. J Lab Clin Med 77:33-39, 1991